Clinical Trial Update: Special Survey for Long Term Application

View source ↗

Summary

The document announces the completion of a long-term special survey for Novo Nordisk's clinical trial NCT01516229 in patients with Achondroplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Achondroplasia | Status: COMPLETED